Michael Thomas Ropacki

Michael Thomas Ropacki

Corporate Officer/Principal presso ORYZON GENOMICS S.A.

Health Technology
Consumer Services
Commercial Services

Profilo

Michael Thomas Ropacki is currently the Chief Medical Officer-CNS at Oryzon Genomics SA and the President at Strategic Global Research & Development.
Previously, he worked as the Director-Clinical Development & Neuroscience at Janssen Research & Development LLC from 2013 to 2016, the Head-Global Medical Affairs at Janssen Alzheimer Immunotherapy from 2011 to 2013, and the Senior Vice President-Clinical Development at MedAvante-ProPhase, Inc. in 2017.
He holds a doctorate degree from Texas Tech University.

Posizioni attive di Michael Thomas Ropacki

SocietàPosizioneInizio
ORYZON GENOMICS S.A. Corporate Officer/Principal 01/02/2021
Strategic Global Research & Development President -
Tutte le posizioni attive di Michael Thomas Ropacki

Precedenti posizioni note di Michael Thomas Ropacki

SocietàPosizioneFine
MedAvante-ProPhase, Inc. Chief Tech/Sci/R&D Officer 01/10/2017
Chief Tech/Sci/R&D Officer 01/02/2016
Janssen Alzheimer Immunotherapy Chief Tech/Sci/R&D Officer 01/05/2013
Vedi nel dettaglio l'esperienza di Michael Thomas Ropacki

Formazione di Michael Thomas Ropacki

Texas Tech University Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael Thomas Ropacki

Relazioni

24

Relazioni di 1° grado

6

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa1
ORYZON GENOMICS S.A.

Health Technology

Aziende private4
Janssen Alzheimer Immunotherapy

Commercial Services

MedAvante-ProPhase, Inc.

Strategic Global Research & Development

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Michael Thomas Ropacki